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Abstract
Background: Acute stroke patients are usually transported 
to the nearest hospital regardless of their required level of 
care. This can lead to increased pressure on emergency de-
partments and treatment delay. Objective: The aim of the 
study was to explore the benefit of a mobile stroke unit 
(MSU) in the UK National Health Service (NHS) for reduction 
of hospital admissions. Methods: Prospective cohort audit 
observation with dispatch of the MSU in the East of England 
Ambulance Service area in Southend-on-Sea was conduct-
ed. Emergency patients categorized as code stroke and 
headache were included from June 5, 2018, to December 
18, 2018. Rate of avoided admission to the accident and 
emergency (A&E) department, rate of admission directly to 
target ward, and stroke management metrics were as-
sessed. Results: In 116 MSU-treated patients, the following 
diagnoses were made: acute stroke, n = 33 (28.4%); transient 
ischaemic attacks, n = 13 (11.2%); stroke mimics, n = 32 
(27.6%); and other conditions, n = 38 (32.8%). Pre-hospital 
thrombolysis was administered to 8 of 28 (28.6%) ischaemic 
stroke patients. Pre-hospital diagnosis avoided hospital ad-
mission for 29 (25.0%) patients. As hospital treatment was 
indicated, 35 (30.2%) patients were directly triaged to the 
stroke unit, 1 patient (0.9%) even directly to the catheter 
laboratory. Thus, only 50 (43.1%) patients required transfer 
This is an Open Access article licensed under the Creative Commons 
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to the A&E department. Moreover, the MSU enabled throm-
bolysis with a median dispatch-to-needle time of 42 min (in-
terquartile range, 40–60). Conclusion: This first deployment 
of an MSU in the UK NHS demonstrated improved triage 
decision-making for or against hospital admission and ad-
mission to the appropriate target ward, thereby reducing 
pressure on strained A&E departments.
© 2020 The Author(s)
Published by S. Karger AG, Basel
Introduction
Stroke is the second largest cause of death for persons 
older than 60 years and contributes to most adult dis-
abilities [1]. In the UK, more than 85,000 patients are ad-
mitted annually to hospitals because of new acute stroke 
[2], and this number is expected to increase by 44% by 
2035 [3].
Unfortunately, most patients arrive at the hospital too 
late for effective treatment. Only 15–60% of acute stroke 
patients arrive at the hospital within 3 h after the onset of 
symptoms [4]. This delay dramatically reduces the chanc-
es of a good outcome [5] and is an important reason for 
the observed low rates of thrombolysis (<12%) and 
thrombectomy (<0.5%) [2, 6].
Acute stroke management is further complicated by a 
wide spectrum of medical conditions that clinically re-
semble stroke (stroke mimics), many of which do not 
warrant hospital admission. Because of insufficient diag-
nostic tools at the emergency site, it is often impossible to 
determine whether a patient requires hospital care or, if 
so, which level of stroke care the target hospital should 
offer. The default pre-hospital approach tends to be to 
transfer patients to the nearest accident and emergency 
(A&E) department, even though they could have been 
safely and effectively treated in the community had the 
diagnosis been known. This fact contributes to the in-
creasing numbers of patients treated in hospital A&E de-
partments in recent years. It has been reported that a sub-
stantial proportion of A&E department patients could 
have reasonably been treated by a general practitioner 
and that approximately 40% of patients who arrive at an 
A&E department are discharged without requiring treat-
ment [7].
The MSU is a specialized ambulance that incorporates 
a multimodal computed tomography (CT) scanner, a 
point-of-care (POC) laboratory, and telemedicine com-
munication to the hospital [8, 9], in addition to standard 
ambulance equipment. Studies of pre-hospital stroke 
management report not only dramatic reductions in de-
lays before thrombolysis [10–13] but also the potential for 
diagnosis-based triage decision-making [14, 15]. This 
project aimed to investigate whether an MSU approach 
for pre-hospital acute stroke diagnosis can help avoid un-
necessary A&E admissions and improve the delivery of 
rapid recanalizing acute stroke treatment in the UK Na-
tional Health Service (NHS).
Methods
Patients and Study Setting
We conducted this prospective clinical audit (audit number 
18034) from June 5, 2018, to December 18, 2018. During this pe-
riod, the MSU was in service for 62 days. All patients or patient 
representatives gave written informed consent for participation in 
this evaluation.
The MSU was stationed at the East of England Ambulance Ser-
vice NHS Trust (EEAST) emergency medical service (EMS) sta-
tion in Southend-on-Sea, UK. The MSU operated in a 15-mile ra-
dius around the Southend-on-Sea ambulance station. This area is 
populated by 184,437 inhabitants, 36% of whom are older than 65 
years. The MSU was in operation from 9:00 a.m. to 5:00 p.m., 5 
days per week. The EMS dispatcher activated the MSU for acute 
stroke (dispatch code 28; dispatchers used the Face, Arm, Speech, 
Time [FAST] questionnaire) or acute severe headache (dispatch 
code 18). For the first 6 weeks of the study, the MSU was combined 
with an additional rapid response vehicle; thereafter, it was dis-
patched alone.
MSU Technology
The MSU is an ambulance that contains, in addition to stan-
dard emergency equipment, the following specialized equipment 
[10]: (1) an accumulator-driven CT scanner (CereTom, Neuro-
logica/Samsung, Danvers, MA, USA) enabling multimodal imag-
ing; (2) automated image analysis (e-Stroke Suite, Brainomix Ltd., 
Oxford, UK); (3) a telemedicine system (aycan Digitalsysteme 
GmbH, Wuerzburg, Germany) enabling videoconferencing and 
transmission of videos of the patient’s examination and of CT 
scans; and (4) a POC laboratory system for determining full blood 
count (PocH 100i, Sysmex, Hamburg, Germany), international 
normalized ratio and activated partial thromboplastin time (He-
mochron Elite, ITC, Edison, NY, USA), and creatinine levels (Stat-
Sensor, Nova Biomedical, Waltham, MA, USA).
The MSU was staffed with 1 paramedic and 1 stroke physician, 
and 1 study observer documenting stroke management metrics. In 
this experimental setting, a radiologist was onboard for the first 50 
cases; thereafter, images were analysed remotely by hospital radi-
ologists available via telemedicine.
MSU-Based Stroke Management
The MSU intervention consisted of a medical history, general 
clinical and neurological assessment, and POC laboratory tests, 
and, if clinically indicated, of non-contrast CT studies, and CT an-
giography and CT perfusion studies. CT angiography was per-
formed if patients had a score of 7 or higher on the National Insti-
tutes of Health Stroke Scale (NIHSS), a hyperdense middle cere-




bral artery sign on a non-contrast CT image, or recurrent symptoms 
of unknown onset. If indicated, IV thrombolysis (with recombi-
nant tissue plasminogen activator) was administered directly at the 
emergency site. On the basis of the obtained pre-hospital informa-
tion, the MSU staff decided whether hospital admission was neces-
sary and, if hospital treatment was required, which target ward 
would be the most appropriate.
Clinical Assessments
Assessments included a medical history and general clinical 
and neurological examinations. All patients were evaluated with 
the Glasgow Coma Scale (GCS), the modified Rankin Scale (mRS), 
the NIHSS, and the Los Angeles Motor Scale (LAMS).
Triage Decision Assessment
Rational triage decision-making was achieved by tabulating the 
rate of avoided transfers to the hospital’s A&E department. This 
rate was defined as the sum of cases for which pre-hospital diag-
nosis allowed either a decision against hospital admission or en-
abled direct admission to the appropriate ward (stroke unit or 
catheter laboratory). Triage accuracy was confirmed by a blinded 
independent rater (an independent A&E physician) who reviewed 
the pre-hospital and in-hospital documents.
Stroke Management Metrics
The following stroke management metrics were evaluated: 
time from 999 emergency call to (1) MSU dispatch and (2) MSU 
mobile; and time from MSU dispatch to (3) MSU mobile, (4) ar-
rival on scene, (5) first contact to stroke consultant, (6) end of non-
contrast CT, (7) end of CT angiography, (8) therapy decision (de-
fined as end of all required diagnostic procedures: neurological 
examination, POC laboratory testing, and imaging), (9) IV throm-
bolysis (if indicated), (10) triage decision, (11) end of MSU mission 
(defined as time of handover to hospital staff), and (12) groin 
puncture for patients requiring intra-arterial therapy.
Safety Parameters
The incidence of serious adverse events, including death and 
stroke-related deterioration (resulting in an increase of at least 4 
points in the NIHSS), was documented in the pre-hospital phase 
and during the hospital stay.
Statistical Analysis
Stroke management metrics and epidemiological information 
were expressed as medians (interquartile range) and diagnoses and 
triage destinations as frequencies (percentage). Only patients with 
known symptom onset time were taken into account for analysis 
of symptom onset time metrics.
Results
Demographic and Clinical Characteristics
The audit involved 116 patients (66 women, 50 men; 
median age, 79 years; interquartile range, 65–86 years) 
with symptoms of acute stroke or headache. All patients 
agreed to participate in the audit evaluation. Baseline de-
mographics and clinical characteristics of patients are 
presented in Table  1. Four representative cases are de-
scribed in Figure 1.
MSU Triage Decisions
On the basis of pre-hospital diagnosis, 29 patients 
(25.0%) were effectively treated in the pre-hospital setting 
rather than being transported to the hospital. The diag-
nostic groups and their triage pathways are presented in 
Figure 2.
Moreover, when hospital-based treatment was indi-
cated, aetiology-based transport to a specialized ward 
(stroke unit, catheter laboratory, or transient ischaemic 




Age, years 79 (65–86)
Female sex 66 (56.9)
Male sex 50 (43.1)
Cardiovascular comorbidities 64 (55.2)
Neurological comorbidities 62 (53.4)
Previous cerebral infarction 14 (22.2)
GCSa 15 (14–15)
NIHSS scoreb 6 (4–7.25)
Pre-mRSb 1 (0–3)
mRSb 4 (3–4)
mRS dischargeb 3 (2–4)
LAMSb 3 (1–3)
Diagnosis
Ischaemic stroke 28 (24.1)
Intracranial haemorrhage 5 (4.3)
TIA 13 (11.2)
Stroke mimics 32 (27.6)
Other conditions 38 (32.8)
Triage destination
A&Ec 50 (43)
Stroke unit 35 (30)
Catheter laboratory 1 (1)
Left at ambulatory setting 29 (25)
Including TIA clinic referrals 2 (2)
Air-lifted directly to comprehensive centre 
without MSU assessment on scene 1 (1)
Medical characteristics are presented as median (interquartile 
range) and sex, comorbidities, diagnosis, and triage destination 
data as frequency (percentage). A&E, accident and emergency; 
GCS, Glasgow Coma Scale; LAMS, Los Angeles Motor Scale; mRS, 
modified Rankin Scale; MSU, mobile stroke unit; NIHSS, Nation-
al Institutes of Health Stroke Scale; TIA, transient ischaemic at-
tack. a All patients. b Only stroke patients. c Including 5 patients 
initially triaged to a stroke unit but who had to be transferred to 
A&E due to transient shortage of beds on the stroke unit.




Fig. 1. Exemplary cases of MSU deploy-
ment in the UK healthcare system. a A pa-
tient (female, 82 years old) with right-sided 
sensorimotor paresis and severe dysphasia 
(NIHSS 7) seen more than 3 h after onset. 
After pre-hospital diagnosis including CT, 
thrombolysis was administered directly at 
the emergency site. b A patient (female, 51 
years old) with thunderclap headache and 
nausea (NIHSS 1). Pre-hospital imaging 
enabled the diagnosis of SAH at the emer-
gency site. The nearest neurovascular cen-
tre was pre-notified. c A patient (male, 89 
years old) with severe sensorimotor hemi-
paresis (NIHSS 16). Pre-hospital vascular 
imaging revealed LVO (white arrow) as the 
basis for direct transfer to the catheter lab-
oratory, thus bypassing the A&E Depart-
ment. d A patient (male, 73 years old) for 
whom pre-hospital diagnosis of a stroke 
mimic (Bell’s palsy) allowed for a triage de-
cision against hospital admission, and for 
phoning the patient’s general practitioner 
for oral steroid treatment in the pre-hospi-
tal setting. NIHSS, National Institutes of 
Health Stroke Scale; SAH, subarachnoid 
haemorrhage; LVO, large vessel occlusion; 
MSU, mobile stroke unit; CT, computed 
tomography; A&E, accident and emergen-
cy.
Included patients (n = 116)
Ambulatory
setting (n = 29)
• TIA (n = 3)
• Mimics (n = 8)








   strokes (n = 21)
• ICH (n = 1)
• TIA (n = 7)
• Mimics (n = 6)
Neurosurgery
(n = 1)
• ICH (n = 1) 
A&E (n = 50)
• Ischaemic
   strokes (n = 6)
• ICH (n = 3)
• TIA (n = 3)
• Mimics (n = 18)
• Others (n= 20)
Fig. 2. Flowchart of included patients. A&E, accident and emergency; ICH, intracranial haemorrhage; TIA, tran-
sient ischaemic attack.




attack [TIA] clinic) was accomplished for 38 (32.8%) pa-
tients: 35 patients (30.2%) were taken to a stroke unit, 1 
patient (0.9%) was taken to a catheter laboratory, and 2 
patients (1.7%) were taken to a TIA clinic. These pa-
tients were directly handed over from the EMS person-
nel to the specialists in the target ward or were left at 
home when referral to a TIA clinic was required. One 
patient (0.9%) did not undergo MSU assessment be-
cause of clinical instability; this patient required direct 
air transportation to a comprehensive centre nearest to 
the emergency site.
A triage decision for transport to an A&E department 
was made for 45 (38.8%) patients (Table 1). For an addi-
tional 5 (4.3%) stroke patients, despite pre-hospital diag-
nosis and pre-notification of the stroke unit, a planned 
direct transfer to that unit could not be realized because 
of unavailability of beds at that time. Thus, the overall 
number of patients transferred to an A&E department 
was 50 (43.1%). The diagnosis of the non-stroke patients 
and their triage destination is detailed in online suppl. 
Table 1; see www.karger.com/doi/10.1159/000508910.
Comparison of triage decisions by the MSU team and 
those of the blinded independent A&E physician rater 
showed that this rater would have left 3 (2.6%) more pa-
tients at home than the MSU team did. Importantly, the 
MSU team left no patient at home who was judged by the 
rater to require hospital treatment. The independent rat-
er would have triaged 5 more patients to the stroke unit 
(4.3%; 3 with intracranial haemorrhage or subarachnoid 
haemorrhage). The MSU team transferred these patients 
to the A&E resuscitation area that offered a higher level 
of care instead. The rater would have directly triaged 1 
Table 2. Stroke management metrics (median, interquartile range)




Symptom onset to 999 call 50 (8–172)
Emergency 999 call to MSU dispatch 7 (4–15)
Symptom onset to MSU dispatch (MSU call) 61 (21–188)
MSU dispatch (MSU call) to MSU mobile (start of mission) 2 (0–3)
Emergency 999 call to MSU mobile 10 (6–18)
MSU dispatch to on-scene arrival 13 (11–18)
Symptom onset to on-scene arrival 78 (35–203)
Distance covered, km 10.4 (6.3–19.3)
MSU dispatch to first contact to MSU consultant 15 (12–18)
Door to first contact to stroke consultant (in person) 616 578
MSU dispatch to end of non-contrast CT 46 (39–53)
MSU dispatch to end of non-contrast CTb 37 (35–51)
MSU dispatch to end of CT-angiography 60 (56–64); n = 10
MSU dispatch to therapy decisionc 36 (23–50)
MSU dispatch to therapy decisionb, c 38 (36–53)
MSU dispatch to needleb 42 (40–60); n = 8
Hospital door to needle 50 75
MSU dispatch to triage decision 41 (28–55)
MSU arrival on scene to end of non-contrast CT 31 (26–35)
MSU arrival on scene to end of non-contrast CTb 30 (21–35)
MSU arrival on scene to therapy decisionc 21 (21–33)
MSU arrival to therapy decisionb, c 31 (21–38)
MSU arrival to needleb 33 (26–45)
Onset to needle 115 (100–189) 146 155
On-scene duration 45 (38–59)
Emergency 999 call to hospital door 65 65
MSU dispatch to groin puncture 122; n = 1
MSU dispatch to end of mission (handover at hospital) 81 (68–102)
Data are displayed as median (interquartile range), unless otherwise noted. a  Register data from July to 
December 2018 (audit data SSNAP and EEAST). b Only tPA patients. c Defined as end of diagnostic workup with 
clinical examination, CT scan, and laboratory as indicated.
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stroke mimic (0.9%) to the A&E department, whereas the 
MSU team triaged this patient to the stroke unit.
Regarding the number of CTs required to differentiate 
stroke mimics and other conditions from stroke, non-
contrast CT was performed for 22 of 32 stroke mimics 
and for 6 of 38 other medical conditions, and CT angiog-
raphy was performed for 4 stroke mimics. All other non-
stroke patients were diagnosed by clinical examination 
and POC laboratory.
Stroke Management Metrics
MSU-based stroke management metrics are shown in 
Table  2. The thrombolysis rate for patients with acute 
ischaemic stroke was 29%. Median times from MSU dis-
patch-to-needle of 42 min (40–60 min) were achieved. 
These times compare favourably with door-to-needle 
times regionally and nationwide (Table 2). Similar bene-
fits were observed in the other stroke management met-
rics (Table  2). Amongst patients who obtained throm-
bolysis, the EMS was alerted a median of 66 min (46–141 
min) after symptom onset; thus, the time of the alert was 
often already past the first “golden” hour time window.
Short-Term Outcomes and Safety
The mRS of stroke patients at discharge was 3 (2–4) 
(Table 1). No complications occurred in the pre-hospital 
phase of acute stroke management. No patient who re-
ceived IV thrombolysis in the MSU experienced compli-
cations with bleeding. In the hospital, 1 patient (0.9%) 
died of stroke-related causes: this patient experienced se-
vere subarachnoid haemorrhage related to anticoagula-
tion treatment. Five patients (4.3%) died of causes not 
related to stroke.
Discussion
This study showed that MSU-based stroke manage-
ment allowed to avoid hospital A&E admissions. This was 
accomplished by pre-hospital triage decision-making 
against hospital admissions in 25% of the patients and 
direct admission to the required specialized target ward. 
In fact, 30% of the patients were directly taken to the 
stroke unit and 1 patient with large vessel occlusion even 
directly to the catheter laboratory for intra-arterial ther-
apy. Thus, in total, admission to the hospital’s A&E de-
partment was avoided for 55% of the patients.
The role of MSUs in pre-hospital triage decision-mak-
ing may be relevant because unnecessary hospital admis-
sions are not only expensive but may also be associated 
with adverse medical consequences, such as an increased 
risk of delirium, depression, poor quality of life, health-
care-acquired infections, and falls. This finding is in line 
with estimates showing that approximately one-fifth to 
one-third of admissions of frail and elderly patients could 
be avoided by an early review by a qualified clinical deci-
sion-maker [16].
Moreover, MSU-based stroke management enabled 
ultra-early thrombolysis with an MSU dispatch-to-nee-
dle time of 42 min and a thrombolysis rate of 29%, which 
is higher than the national UK average of 11–12%. The 
observed times to treatment are amongst the fastest re-
ported times to treatment in clinical studies and registries 
to date [17]. This call-to-needle time compares favour-
ably even with in-hospital mean door (of the hospital)-to-
needle times of 50 min at a national level [18]. This reduc-
tion in delay can be explained by both the reduced trans-
port times and the increased efficiency between the 
various groups of healthcare professionals involved in the 
complex stroke rescue chain. However, the finding of a 
relevant delay before EMS alert in most patients under-
lines the necessity of public awareness campaigns for 
stroke in this region. Safety endpoints were comparable 
to those of other studies investigating MSUs [10, 11].
The main indication for deploying the MSU was acute 
stroke. Stroke mimics and other conditions could be dif-
ferentiated at the emergency site, and differential triage 
to the most appropriate target destination was possible. 
Conditions other than stroke were treated convention-
ally; in this case, the MSU functioned as a normal ambu-
lance.
A limitation of this study is that patients were not ran-
domly assigned to a control group because of the audit 
format of this intervention. Besides, the study population 
was relatively small. Therefore, additional research is nec-
essary for assessing clinical benefits with long-term fol-
low-up data.
A current problem for efficient use of MSUs is the sub-
optimal dispatch accuracy for stroke in general, which 
means that the MSU team sees a high percentage of non-
stroke cases. Indeed, poor accuracy of the detection of 
stroke in the EMS dispatch office is increasingly being 
recognized, and sensitivities ranging between 41 and 73% 
have recently been reported in a meta-analysis of 5 large 
studies [19].
Current efforts aimed at reducing the number of false 
dispatches include improving the training of healthcare 
personnel at the dispatch location, improving dispatch 
algorithms, and using scales for stroke recognition. Other 
approaches currently being explored are pre-evaluation 




of patients by the first arriving EMS team and cancella-
tion of MSU dispatch when the absence of stroke has been 
determined [20]. More research is needed to optimize 
dispatch accuracy.
In the future, the cost-effectiveness of the MSU may be 
improved by substituting on-board physicians by tele-
medicine-linked remote experts. Health economic analy-
sis in the NHS context is necessary. In conclusion, this 
first experience in the UK healthcare system demon-
strates that, apart from enabling ultra-early thrombolysis, 
this approach allows for accurate triage decisions at the 
emergency site, thereby reducing unnecessary admis-
sions to currently strained A&E departments.
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